Zinc(II)—The Overlooked Éminence Grise of Chloroquine’s Fight against COVID-19?
Zn(II) is an inhibitor of <i>SARS-CoV-2</i>′s RNA-dependent RNA polymerase, and chloroquine and hydroxychloroquine are Zn(II) ionophores–this statement gives a curious mind a lot to think about. We show results of the first clinical trials on chloroquine (CQ) and hydroxychloroquine (HCQ)...
Main Authors: | Aleksandra Hecel, Małgorzata Ostrowska, Kamila Stokowa-Sołtys, Joanna Wątły, Dorota Dudek, Adriana Miller, Sławomir Potocki, Agnieszka Matera-Witkiewicz, Alicia Dominguez-Martin, Henryk Kozłowski, Magdalena Rowińska-Żyrek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/13/9/228 |
Similar Items
-
SARS-CoV-2 and the Use of Chloroquine as an Antiviral Treatment
by: Mathieu E. Rebeaud, et al.
Published: (2020-04-01) -
New Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine
by: Davide Gentile, et al.
Published: (2020-08-01) -
Side effects of long-term treatment with chloroquine for rheumatoid arthritis - a review of the literature
by: Sylwia Zdun, et al.
Published: (2022-12-01) -
Chloroquine sulphate and chloroquine phosphate (chloroquine diphosphate)
by: 982 SIRIM -
Chloroquine for COVID-19: rationale, facts, hopes
by: Andrea Cortegiani, et al.
Published: (2020-05-01)